TNBI — Tanke Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual balance sheet for Tanke Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2008 December 31st	2009 December 31st	R2010 December 31st	C2011 December 31st	C2012 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-Q
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0	0	2.22	7.7	6.17
Net Total Accounts Receivable
Net Total Receivables	—	—	3.8	2.16	1.99
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.001	0	7.67	18.9	22.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	4.33	4.81	5.11
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	0.001	0	13.3	24.9	28.8
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.017	0.032	2.41	3.55	12.1
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.017	0.032	5.1	9.03	13.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.017	-0.032	8.16	15.9	15.8
Total Liabilities & Shareholders' Equity	0	0	13.3	24.9	28.8
Total Common Shares Outstanding